Krittiya Korphaisarn

KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer

Wenting Liao, Michael J. Overman, Adam T. Boutin et al. · Cancer Cell · 2019 · 610 citations · Full text

Medicine, Cancer Biology, Oncology +16

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 488 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Validation of <i>HER2</i> Amplification as a Predictive Biomarker for Anti–Epidermal Growth Factor Receptor Antibody Therapy in Metastatic Colorectal Cancer

Kanwal Pratap Singh Raghav, Jonathan M. Loree, Jeffrey S. Morris et al. · JCO Precision Oncology · 2019 · 132 citations

Medicine, Oncology, Pathology +15

<i>FBXW7</i> missense mutation: a novel negative prognostic factor in metastatic colorectal adenocarcinoma

Krittiya Korphaisarn, Van K. Morris, Michael J. Overman et al. · Oncotarget · 2017 · 69 citations · Full text

Medicine, Genetics, Oncology +17

Signet ring cell colorectal cancer: genomic insights into a rare subpopulation of colorectal adenocarcinoma

Krittiya Korphaisarn, Van K. Morris, Jennifer S. Davis et al. · British Journal of Cancer · 2019 · 66 citations · Full text

Medicine, Molecular Genetics, Oncology +17